{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:01:32Z","timestamp":1791237692950,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1513,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1365-2133.2011.10397.x","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T16:37:16Z","timestamp":1305218236000},"page":"335-341","source":"Crossref","is-referenced-by-count":73,"title":["Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart"],"prefix":"10.1093","volume":"165","author":[{"given":"A.V.","family":"Marzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Polloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Crosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,11]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archderm.1945.01510210032007","article-title":"Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus","volume":"51","author":"Hoffman","year":"1945","journal-title":"Arch Derm Syphilol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1056\/NEJM198806023182209","article-title":"Drug-related lupus","volume":"318","author":"Hess","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1067\/mjd.2001.116583","article-title":"Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized","volume":"45","author":"Callen","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.115.12.1409","article-title":"Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-4362.2001.01067-5.x","article-title":"Subacute cutaneous lupus erythematosus with pityriasis-like cutaneous manifestations","volume":"40","author":"Caproni","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2230.2009.03240.x","article-title":"Paraneoplastic toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus","volume":"35","author":"Torchia","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1571-5078(05)05007-5","volume-title":"The Skin in Systemic Autoimmune Disease","author":"Sontheimer","year":"2006"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000073091","article-title":"Poikilodermatous subacute cutaneous lupus erythematosus","volume":"207","author":"Marzano","year":"2003","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1365-2133.1999.03118.x","article-title":"Lupus erythematosus with antiphospholipid syndrome and erythema multiforme-like lesions","volume":"141","author":"Marzano","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","article-title":"Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus","volume":"97","author":"Sontheimer","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","article-title":"Drug-induced lupus: an update on its dermatologic aspects","volume":"18","author":"Marzano","year":"2009","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB14|cit14","first-page":"54","article-title":"Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT)","volume":"11","author":"Yoshimasu","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB15|cit15","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB17|cit17","first-page":"213","article-title":"Nitrendipine-induced subacute cutaneous lupus erythematosus","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1468-3083.2005.01233.x","article-title":"Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature","volume":"19","author":"Aydogan","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0961203307087189","article-title":"Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions","volume":"17","author":"Marzano","year":"2008","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2230.2008.02972.x","article-title":"Rowell\u2019s syndrome in the course of treatment with sodium valproate: a case report and review of the literature data","volume":"34","author":"Kacalak-Rzepka","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archderm.1963.01590200064012","article-title":"Lupus erythematosus and erythema multiforme-like lesions. A syndrome with characteristic immunological abnormalities","volume":"88","author":"Rowell","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/000155500750012289","article-title":"Erythema multiforme-like subacute cutaneous lupus erythematosus: a new variety?","volume":"80","author":"Massone","year":"2000","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1191\/0961203304lu1056cr","article-title":"Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus","volume":"13","author":"Geraminejad","year":"2004","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clindermatol.2003.12.023","article-title":"Drug-induced lupus erythematosus","volume":"22","author":"Antonov","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.2009.09472.x","article-title":"Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients","volume":"162","author":"Vera-Recabarren","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB26|cit26","first-page":"549","volume-title":"Dubois\u2019 Lupus Erythematosus","author":"Norris","year":"1997"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1365-2133.2001.04182.x","article-title":"Apoptosis in different cutaneous manifestations of lupus erythematosus","volume":"144","author":"Baima","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/039463200702000313","article-title":"Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"20","author":"Marzano","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/3-540-26581-3_19","volume-title":"Cutaneous Lupus Erythematosus","author":"Nyberg","year":"2005"},{"key":"10.1111\/j.1365-2133.2011.10397.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.22699","article-title":"Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus","volume":"56","author":"Franz","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10397.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10397.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:52:18Z","timestamp":1676382738000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/165\/2\/335\/6644276"}},"subtitle":["Drug-induced subacute cutaneous lupus erythematosus"],"short-title":[],"issued":{"date-parts":[[2011,7,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10397.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,11]]}}}